IMPACT OF CHRONIC KIDNEY DISEASE ON CARDIOVASCULAR RISK IN MIDDLE-AGED ADULTS: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.71000/t3qdq135Keywords:
Chronic Kidney Disease, Middle-aged Adults, Hypertension, , Systematic Review, Cardiovascular Risk, Left Ventricular HypertrophyAbstract
Background: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD), yet the specific risk burden among middle-aged adults remains underexplored. While previous studies have established a general link between CKD and cardiovascular complications, limited data focus on early-stage renal impairment in the 35–65 age group. This review addresses a critical gap in understanding the cardiovascular implications of CKD in this population.
Objective: This systematic review aims to evaluate the association between chronic kidney disease and cardiovascular risk in middle-aged adults, with a focus on outcomes such as hypertension, left ventricular hypertrophy, and ischemic events.
Methods: A systematic review was conducted following PRISMA guidelines. Four databases—PubMed, Scopus, Web of Science, and Cochrane Library—were searched for studies published in the last five years. Inclusion criteria comprised observational studies, cohort studies, and review articles involving adults aged 35–65 years with diagnosed CKD. Data extraction was performed using standardized forms, and study quality was assessed using the Newcastle-Ottawa Scale.
Results: Eight studies met the inclusion criteria. Findings consistently demonstrated that CKD in middle-aged adults significantly increases the risk of cardiovascular events. One population-based cohort study reported adjusted hazard ratios of 2.26 for ischemic heart disease and 8.57 for heart failure in CKD patients compared to controls. Other studies emphasized mechanisms such as vascular calcification, oxidative stress, and systemic inflammation as contributors to cardiovascular pathology in CKD.
Conclusion: CKD is an independent and substantial risk factor for cardiovascular complications in middle-aged adults. These findings highlight the need for early cardiovascular risk assessment and intervention in this population. While evidence is robust, further prospective studies are needed to confirm causality and refine management strategies.
References
Tsur AM, Akavian I, Landau R, Derazne E, Tzur D, Vivante A, et al. Adolescent Body Mass Index and Early Chronic Kidney Disease in Young Adulthood. JAMA Pediatr. 2024;178(2):142-50.
Wu G, Cai M, Wang C, Zou H, Wang X, Hua J, et al. Ambient air pollution and incidence, progression to multimorbidity and death of hypertension, diabetes, and chronic kidney disease: A national prospective cohort. Sci Total Environ. 2023;881:163406.
Liu W, Weng S, Cao C, Yi Y, Wu Y, Peng D. Association between monocyte-lymphocyte ratio and all-cause and cardiovascular mortality in patients with chronic kidney diseases: A data analysis from national health and nutrition examination survey (NHANES) 2003-2010. Ren Fail. 2024;46(1):2352126.
Cao B, Guo Z, Li DT, Zhao LY, Wang Z, Gao YB, et al. The association between stress-induced hyperglycemia ratio and cardiovascular events as well as all-cause mortality in patients with chronic kidney disease and diabetic nephropathy. Cardiovasc Diabetol. 2025;24(1):55.
Liang Y, Chen H, Liu Y, Hou X, Wei L, Bao Y, et al. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China. J Clin Endocrinol Metab. 2022;107(1):88-97.
Ren Y, Cai Z, Guo C, Zhang Y, Xu H, Liu L, et al. Associations Between Life's Essential 8 and Chronic Kidney Disease. J Am Heart Assoc. 2023;12(24):e030564.
Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation. 2021;143(11):1157-72.
Valladares P, Ruiz S, Pineda I, Bermudez U, Velázquez M, Aguilar A, et al. Cardiovascular risk in individuals with kidney disease. International Journal Of Community Medicine And Public Health. 2024.
Shukurova S, Rashidov I. Chronic kidney disease and cardiovascular disease: is there a connection? Health care of Tajikistan. 2024.
Ascaso J, Carmena R, Redón J. Chronic kidney disease as a cardiovascular risk factor. Journal of Hypertension. 2020;38:2110-21.
Domislović M, Domislović V, Stevanović R, Fuček M, Dika Ž, Karanović S, et al. CHRONIC KIDNEY DISEASE IN RURAL POPULATION. Acta Clin Croat. 2022;61(2):228-38.
Vieira de Oliveira Salerno PR, Lewis PGT, Chen Z, Dazard JE, Ganatra S, Ahmed EN, et al. Climate Vulnerability and Cardiovascular-Kidney-Metabolic Disease in the United States. J Am Heart Assoc. 2025;14(11):e038251.
Goto H, Iseri K, Hida N. Fibrates and the risk of cardiovascular outcomes in chronic kidney disease patients. Nephrol Dial Transplant. 2024;39(6):1016-22.
Ferguson LD, Molenberghs G, Verbeke G, Rahimi K, Rao S, McInnes IB, et al. Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls. Lancet Rheumatol. 2024;6(3):e156-e67.
Cho S, Yoo T, Lee H-Y, Jeon J, Kim H, Lee Yh. Ideal cardiovascular health duration and risk of chronic kidney disease and cardiovascular disease. Heart. 2021;108:523-8.
Lin Y-N, Chang K-H, Hsu W, Wu C-H, Chen S-Y, Wang C-Y. Incidence and risk of major adverse cardiovascular events in middle-aged patients with chronic kidney disease: a population-based cohort study. International Urology and Nephrology. 2019;51:1219-27.
Vondenhoff S, Noels H, Schunk S. Increased cardiovascular risk in patients with chronic kidney disease. Herz. 2024;49:95-104.
Batra G, Ghukasyan Lakic T, Lindbäck J, Held C, White HD, Stewart RAH, et al. Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome. JAMA Cardiol. 2021;6(12):1440-5.
Huo Z, Huang Z, Feng J, Li J, Chen S, Wang G, et al. Life's Essential 8 and heart failure among patients with chronic kidney disease: the Kailuan Cohort Study. Eur J Prev Cardiol. 2024;31(7):824-31.
Podadera-Herreros A, Alcala-Diaz JF, Gutierrez-Mariscal FM, Jimenez-Torres J, Cruz-Ares S, Arenas-de Larriva AP, et al. Long-term consumption of a mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: The CORDIOPREV randomized controlled trial. Clin Nutr. 2022;41(2):552-9.
Mark PB, Carrero JJ, Matsushita K, Sang Y, Ballew SH, Grams ME, et al. Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study. Eur Heart J. 2023;44(13):1157-66.
Agarwal R, Pitt B, Rossing P, Anker SD, Filippatos G, Ruilope LM, et al. Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone. JAMA Cardiol. 2023;8(8):732-41.
Legrand F, Motiejunaite J, Arnoult F, Lahens A, Tabibzadeh N, Robert-Mercier T, et al. Prevalence and factors associated with masked hypertension in chronic kidney disease. J Hypertens. 2024;42(6):1000-8.
Geng T, Xu W, Gao H, Zhang J, Zou J, Wang K, et al. Relationship Between Control of Cardiovascular Risk Factors and Chronic Kidney Disease Progression, Cardiovascular Disease Events, and Mortality in Chinese Adults. J Am Coll Cardiol. 2024;84(14):1313-24.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Emaan Mahmood, Shaheryar Khan, Romaisa Waseem, Mohsin Rasheed, Muzamil Amin, Talha Anwar, Amna Malik, Komal Fatima (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
